Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H15N3O3 |
| Molecular Weight | 285.2979 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(\C=N\NC(=O)C2=CC=NC=C2)C=C1OC
InChI
InChIKey=HPXIKMBHOXLFOR-LICLKQGHSA-N
InChI=1S/C15H15N3O3/c1-20-13-4-3-11(9-14(13)21-2)10-17-18-15(19)12-5-7-16-8-6-12/h3-10H,1-2H3,(H,18,19)/b17-10+
| Molecular Formula | C15H15N3O3 |
| Molecular Weight | 285.2979 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13272716
Mice: Verazide at 10 mg/kg at weekly intervals exhibits a fair degree of activity, and at 30 mg/kg almost completely heals tuberculosis ulcers with only 3 injections.
Route of Administration:
Intramuscular
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13272716
The high in vitro activity of Verazide is 0.06 ug/ml
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:14:35 GMT 2025
by
admin
on
Mon Mar 31 18:14:35 GMT 2025
|
| Record UNII |
XO8D6I4I5L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C280
Created by
admin on Mon Mar 31 18:14:35 GMT 2025 , Edited by admin on Mon Mar 31 18:14:35 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
567
Created by
admin on Mon Mar 31 18:14:35 GMT 2025 , Edited by admin on Mon Mar 31 18:14:35 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104481
Created by
admin on Mon Mar 31 18:14:35 GMT 2025 , Edited by admin on Mon Mar 31 18:14:35 GMT 2025
|
PRIMARY | |||
|
100000079080
Created by
admin on Mon Mar 31 18:14:35 GMT 2025 , Edited by admin on Mon Mar 31 18:14:35 GMT 2025
|
PRIMARY | |||
|
DTXSID4045002
Created by
admin on Mon Mar 31 18:14:35 GMT 2025 , Edited by admin on Mon Mar 31 18:14:35 GMT 2025
|
PRIMARY | |||
|
93-47-0
Created by
admin on Mon Mar 31 18:14:35 GMT 2025 , Edited by admin on Mon Mar 31 18:14:35 GMT 2025
|
PRIMARY | |||
|
9574235
Created by
admin on Mon Mar 31 18:14:35 GMT 2025 , Edited by admin on Mon Mar 31 18:14:35 GMT 2025
|
PRIMARY | |||
|
SUB00039MIG
Created by
admin on Mon Mar 31 18:14:35 GMT 2025 , Edited by admin on Mon Mar 31 18:14:35 GMT 2025
|
PRIMARY | |||
|
C81591
Created by
admin on Mon Mar 31 18:14:35 GMT 2025 , Edited by admin on Mon Mar 31 18:14:35 GMT 2025
|
PRIMARY | |||
|
m523
Created by
admin on Mon Mar 31 18:14:35 GMT 2025 , Edited by admin on Mon Mar 31 18:14:35 GMT 2025
|
PRIMARY | Merck Index | ||
|
180261
Created by
admin on Mon Mar 31 18:14:35 GMT 2025 , Edited by admin on Mon Mar 31 18:14:35 GMT 2025
|
PRIMARY | |||
|
XO8D6I4I5L
Created by
admin on Mon Mar 31 18:14:35 GMT 2025 , Edited by admin on Mon Mar 31 18:14:35 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |